A 3D multiscale model to explore the role of EGFR overexpression in tumourigenesis
From MaRDI portal
Publication:2002113
DOI10.1007/S11538-019-00607-YzbMATH Open1417.92021OpenAlexW2941179769WikidataQ90260098 ScholiaQ90260098MaRDI QIDQ2002113FDOQ2002113
Stefan Hellander, Anass Bouchnita, Andreas Hellander
Publication date: 11 July 2019
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-019-00607-y
Cites Work
- Mathematical modeling of corneal epithelial wound healing
- Growth of necrotic tumors in the presence and absence of inhibitors
- Chaste: A test-driven approach to software development for biological modelling
- A mathematical model of drug resistance: Heterogeneous tumors
- Three-dimensional multispecies nonlinear tumor growth. I: Model and numerical method
- The role of dimerisation and nuclear transport in the Hes1 gene regulatory network
- Multiscale agent-based cancer modeling
- Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression
- Computational modelling of cancer development and growth: modelling at multiple scales and multiscale modelling
Cited In (4)
- Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance
- Phenotype-structured model of intra-clonal heterogeneity and drug resistance in multiple myeloma
- Identifying therapeutic targets in a combined EGFR-TGF\(\beta\)R signalling cascade using a multiscale agent-based cancer model
- A multiscale model to design therapeutic strategies that overcome drug resistance to tyrosine kinase inhibitors in multiple myeloma
Uses Software
This page was built for publication: A 3D multiscale model to explore the role of EGFR overexpression in tumourigenesis
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2002113)
